This Article Full Text Full Text (PDF) All Versions of this Article: 90/4/2205    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Patterson, M. Articles by Bloom, S. R. Search for Related Content PubMed PubMed Citation Articles by Patterson, M. Articles by Bloom, S. R. Related Collections Metabolism

Characterization of Ghrelin-Like Immunoreactivity in Human Plasma

Department of Metabolic Medicine, Imperial College Faculty of Medicine, London Hammersmith Hospital, London W12 ONN, United Kingdom

Address all correspondence and requests for reprints to: Professor Stephen R. Bloom, Department of Metabolic Medicine, Imperial College, London Hammersmith Hospital, Du Cane Road, London W12 ONN, United Kingdom. E-mail: s.bloom{at}imperial.ac.uk.

Ghrelin is a gastric peptide hormone that has an important role in appetite control and GH release. Circulating ghrelin levels are inversely correlated with body mass index and postprandially suppressed. However, the molecular form of circulating ghrelin has not been fully characterized. We studied circulating ghrelin-like immunoreactivity (Ghr-LI) using three RIAs: one specific for only the active, acylated ghrelin (antibody G0–1) and the other two detecting both active and inactive, des-acylated ghrelin (antibody SC and the commercially available Phoenix Pharmaceuticals assay). Plasma ghrelin levels were measured in healthy subjects after a test breakfast (n = 8). Ghr-LI detected by SC and the commercial assay fell significantly at 90 and 120 min post meal (P < 0.01). G0–1 Ghr-LI decreased significantly at 30 min (P < 0.05) post meal and had returned to basal levels at 90 min. Gel permeation chromatography identified three Ghr-LI peaks in plasma. Two G0–1 Ghr-LI peaks with a molecular weight much larger than ghrelin peptide were detected. Only one Ghr-LI peak was detected by the SC and commercial RIA, at the same elution position as synthetic des-acylated ghrelin. These results suggest that the majority of circulating acylated ghrelin is bound to larger molecules, whereas des-acylated ghrelin circulates as free peptide. Assays measuring specific forms of ghrelin may be more useful in determining its physiological role than those that detect both acylated and des-acylated forms.

This article has been cited by other articles:

				J. Liu, C. E. Prudom, R. Nass, S. S. Pezzoli, M. C. Oliveri, M. L. Johnson, P. Veldhuis, D. A. Gordon, A. D. Howard, D. R. Witcher, et al. Novel Ghrelin Assays Provide Evidence for Independent Regulation of Ghrelin Acylation and Secretion in Healthy Young Men J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1980 - 1987. [Abstract] [Full Text] [PDF]

				P. Bech, V. Winstanley, K. G. Murphy, A. H. Sam, K. Meeran, M. A. Ghatei, and S. R. Bloom Elevated Cocaine- and Amphetamine-Regulated Transcript Immunoreactivity in the Circulation of Patients with Neuroendocrine Malignancy J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1246 - 1253. [Abstract] [Full Text] [PDF]

				J. R. C. Parkinson, W. S. Dhillo, C. J. Small, O. B. Chaudhri, G. A. Bewick, I. Pritchard, S. Moore, M. A. Ghatei, and S. R. Bloom PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E698 - E708. [Abstract] [Full Text] [PDF]

				D. H St-Pierre, J.-P. Bastard, L. Coderre, M. Brochu, A. D Karelis, M.-E. Lavoie, F. Malita, J. Fontaine, D. Mignault, K. Cianflone, et al. Association of acylated ghrelin profiles with chronic inflammatory markers in overweight and obese postmenopausal women: a MONET study Eur. J. Endocrinol., October 1, 2007; 157(4): 419 - 426. [Abstract] [Full Text] [PDF]

				E. T. Vestergaard, T. K. Hansen, L. C. Gormsen, P. Jakobsen, N. Moller, J. S. Christiansen, and J. O. L. Jorgensen Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1829 - E1836. [Abstract] [Full Text] [PDF]

				C. Martins, L. M Morgan, S. R Bloom, and M D. Robertson Effects of exercise on gut peptides, energy intake and appetite J. Endocrinol., May 1, 2007; 193(2): 251 - 258. [Abstract] [Full Text] [PDF]

				M. Rauh, M. Groschl, and W. Rascher Simultaneous Quantification of Ghrelin and Desacyl-Ghrelin by Liquid Chromatography-Tandem Mass Spectrometry in Plasma, Serum, and Cell Supernatants Clin. Chem., May 1, 2007; 53(5): 902 - 910. [Abstract] [Full Text] [PDF]

				K. G. Murphy, W. S. Dhillo, and S. R. Bloom Gut Peptides in the Regulation of Food Intake and Energy Homeostasis Endocr. Rev., December 1, 2006; 27(7): 719 - 727. [Abstract] [Full Text] [PDF]

				W. S. Dhillo, P. Savage, K. G. Murphy, O. B. Chaudhri, M. Patterson, G. M. Nijher, V. M. Foggo, G. S. Dancey, H. Mitchell, M. J. Seckl, et al. Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E878 - E884. [Abstract] [Full Text] [PDF]

				C. W. le Roux, R. L. Batterham, S. J. B. Aylwin, M. Patterson, C. M. Borg, K. J. Wynne, A. Kent, R. P. Vincent, J. Gardiner, M. A. Ghatei, et al. Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety Endocrinology, January 1, 2006; 147(1): 3 - 8. [Abstract] [Full Text] [PDF]

				W. S. Dhillo, O. B. Chaudhri, M. Patterson, E. L. Thompson, K. G. Murphy, M. K. Badman, B. M. McGowan, V. Amber, S. Patel, M. A. Ghatei, et al. Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6609 - 6615. [Abstract] [Full Text] [PDF]

				C D R Murray, N M Martin, M Patterson, S A Taylor, M A Ghatei, M A Kamm, C Johnston, S R Bloom, and A V Emmanuel Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study Gut, December 1, 2005; 54(12): 1693 - 1698. [Abstract] [Full Text] [PDF]

				C. Feinle-Bisset, M. Patterson, M. A. Ghatei, S. R. Bloom, and M. Horowitz Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E948 - E953. [Abstract] [Full Text] [PDF]

				O. Gimenez-Palop, G. Gimenez-Perez, D. Mauricio, E. Berlanga, N. Potau, C. Vilardell, J. Arroyo, J.-M. Gonzalez-Clemente, and A. Caixas Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes Eur. J. Endocrinol., July 1, 2005; 153(1): 73 - 79. [Abstract] [Full Text] [PDF]